# Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment

> **NCT00226382** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 50 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Pegylated Interferon-alfa-2a

## Key facts

- **NCT ID:** NCT00226382
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226382, "Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00226382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*